yy易游平台

RESEARCH AND PRODUCTION
RESEARCH AND PRODUCTION

  Home   >  Core technology   >  Gene-Modified Stem Cell Therapy for Monogenic Inherited Diseases


Gene-Modified Stem Cell Therapy for Monogenic Inherited Diseases (Gene-Modified Stem Cell Therapy for Monogenic Inherited Diseases)

Autologous hematopoietic stem cells are collected and ex vivo modified via viral vector-mediated delivery of functional genes, or corrected for pathogenic mutations using gene-editing tools. Following myeloablative conditioning, the corrected stem cells are reinfused back into the patient, allowing the corrected stem cells to engraft in the bone marrow and continuously produce progeny cells with normal function, thereby correcting the genetic defect at its root.

【网站地图】